Firmicutes/Bacteroidetes Ratio

Firmicutes and Bacteroidetes make up most of the bacterial DNA in many adult stool samples. This number divides one by the other. It has been one of the most discussed gut microbiome measurements, and the evidence says it does not do what most people think it does.

That matters before you read your result, because the popular story about this ratio, that a high number means your gut is set up to store fat, has been tested repeatedly in large human cohorts and keeps failing. What the number can do is give you a baseline snapshot of your gut's broad structure to track over time, as one line in a larger stool profile.

What the Number Actually Is

F/B means Firmicutes to Bacteroidetes. It is a stool microbiome calculation. A lab measures bacterial DNA in your stool sample, assigns the signal to broad groups, then divides the share assigned to Firmicutes by the share assigned to Bacteroidetes.

These groups tend to do different work. Bacteroidetes often break down complex plant fibers into acetate and propionate. These are small acids your gut lining and liver can use. Many Firmicutes make butyrate. Butyrate is the main fuel colon cells burn, and it helps maintain the gut wall.

The catch is that each group contains hundreds of genera and thousands of species that behave nothing alike. Faecalibacterium prausnitzii, one of the most consistently protective bacteria in the human gut, is a Firmicute. So are several potentially harmful species. Collapsing all of them into one side of a fraction throws away exactly the information that turns out to matter.

The Obesity Story, and Why It Fell Apart

This is the claim you have almost certainly read: a high ratio means your gut extracts more calories from food and drives weight gain. It came from early animal work and small human cohorts. Larger human studies have not held it up.

A pooled analysis of individual data from eight European studies, covering 7,415 adults, found no relationship between body mass index and Firmicutes, Bacteroidetes, or the ratio between them. In the same analysis, body mass index did track with a genus-level measure, Faecalibacterium, and with lower overall diversity. A separate systematic review and meta-analysis of gut composition in people with and without obesity reported so much heterogeneity between studies that no clear taxonomic difference could be drawn. A meta-analysis of 4,282 stool samples found the relationship pointing the other way, with a higher Bacteroidetes-to-Firmicutes ratio in simple obesity.

Individual cohorts contradict each other outright. An analysis of 61 Ukrainian adults found higher ratios in people with higher BMI. A study of 186 Korean adults found the reverse: people in the highest ratio quartile had roughly 83% lower odds of abdominal obesity than those in the lowest, along with lower insulin resistance scores. A Mexican young-adult cohort and a Croatian follow-up study each found no significant correlation with body fat or weight.

How Both Findings Can Be True

This is not a contradiction that resolves into one side being right. It resolves by recognizing that the ratio is not a good-number, bad-number marker at all. Treat it as a crude structural descriptor of your gut community, like describing a city by its ratio of residential to commercial buildings. The number tells you something real about the shape of the place. It tells you almost nothing about whether the city works.

The useful signal usually lives at the genus and species level. Depletion of specific butyrate producers, expansion of specific harmful species, loss of overall diversity: these track with disease in ways the phylum ratio cannot, because both changes can happen while the ratio stays flat. That is why a high result and a low result can each show up in metabolically healthy people, and why chasing the number itself is the wrong goal.

Where the Ratio Tracks With Disease

Set obesity aside and a few associations recur, though almost all are observational, several point in conflicting directions depending on the study, and none establish cause.

Higher ratios have been reported in first-trimester pregnancy, where the ratio tracked with maternal fasting glucose and later gestational diabetes. Men with prostate enlargement showed higher ratios in a 128-person study. People with irritable bowel syndrome have shown elevated ratios across a systematic review of sequencing studies.

Fatty liver disease is the clearest example of a direction that refuses to settle. One small cohort found the ratio correlated with fibrosis and steatosis stage, while a 126-person study of non-obese fatty liver found the opposite, a ratio of about 0.47 in cases versus 1.4 in controls, and a meta-analysis pooling 28 studies and 3,566 people found no significant phylum-level difference in Firmicutes or Bacteroidetes at all. Do not read a fatty-liver conclusion out of this number.

Lower ratios show up in inflammatory bowel disease, systemic lupus erythematosus, and diabetic retinopathy, generally alongside loss of butyrate-producing species and inflammatory signals. Depression is another split result: one systematic review and meta-analysis found no significant phylum-level difference versus controls despite clear shifts at the genus level, while a standardized multi-cohort analysis of 1,827 samples did find phylum-level change, with more Bacteroidetes and fewer Firmicutes. The genus-level signals are what recur across both.

The one setting with a tested cutoff is not adult medicine, and it used the inverse ratio. In 74 preterm infants, 37 of whom developed necrotizing enterocolitis, a higher Bacteroidetes-to-Firmicutes ratio predicted the condition before symptoms appeared, catching about 82 out of 100 cases and correctly clearing about 81 out of 100 who stayed well. That is a defined population, a defined threshold, and a defined outcome. Nothing like it exists for adults.

Age and Sex Move This Number on Their Own

Before you read anything into your result, subtract what age and sex can do to it. The ratio changes from infancy through adulthood and then shifts again in old age. One founding study reported average ratios of about 0.4 in infants, 10.9 in adults, and 0.6 in elderly people. In a study of 1,550 relatively healthy Ukrainians, the odds of having a ratio above 1.0 rose steadily with age, reaching about 3.7 times higher in men aged 60 to 69 compared with the youngest group.

Sex matters too. In 2,301 adults, women had about 31% higher odds than men of a ratio above 1.0 across the whole sample, and about 56% higher odds among those aged 50 and older. None of that reflects disease. It is the background against which your number sits, and no consumer report adjusts for it well.

Why a Single Reading Can Fool You

Start with the biggest problem: among healthy people, Firmicutes can make up anywhere from 11% to 95% of the community and Bacteroidetes anywhere from 0.6% to 86.6%. That range is real variation between healthy humans, and it is wide enough that no universal normal range exists or reasonably could.

• Stool consistency: looser stool and faster transit shift the balance toward Bacteroidetes, independent of your metabolic health. A sample taken during a loose week reads differently from the same gut during a normal week.
• Lab method: Firmicutes have tougher cell walls. How aggressively a lab breaks open cells during DNA extraction, and which stretch of bacterial DNA it amplifies, changes how much Firmicutes get counted. An interlaboratory study showed the same sample producing different ratios depending on extraction kit and sequencing target, so two labs can hand you different numbers from one stool.
• Blastocystis: this common intestinal protozoan has been associated with a lower ratio in stool studies, without proving your metabolism changed.
• Day-to-day drift: longitudinal tracking shows the ratio swinging widely across consecutive samples within the same person, without correlating stably with BMI or clinical trajectory.

Why One Reading Is Not Enough

Given all of the above, a single result is close to uninterpretable on its own. What is usable is the direction of change in you, sampled the same way, at the same lab, under stable bowel conditions. Your own baseline is the only reference that means anything here.

Use this as a trend only if the sample type, lab, and bowel pattern are comparable. The method matters enough that switching labs can look like biology when it is just measurement.

A caveat on trending: microbial composition tends to drift back toward your baseline once a lifestyle change stops. A shift you produce is a shift you have to keep producing.

How To Read an Out-of-Pattern Result

Do not act on this number alone. Act on the pattern it sits in. If your ratio is unusual, the useful next step is looking at what your panel says one level down: whether Faecalibacterium prausnitzii, Akkermansia muciniphila, and Roseburia are present in reasonable amounts, whether overall diversity is low, and whether any harmful species are expanded. A ratio shift driven by losing your main butyrate producers is a different situation from one driven by a Bacteroides bloom, and only the species-level data distinguishes them.

Pair it with objective markers. Fecal calprotectin tells you whether there is actual gut lining inflammation, which no phylum ratio can establish. A multi-species digital PCR panel discriminates Crohn's disease and ulcerative colitis better than either the ratio or calprotectin alone. On the metabolic side, fasting insulin, HbA1c, triglycerides, and liver enzymes tell you far more about your metabolic state than this ratio ever will, and they are the numbers to act on if they are off.

Involve a gastroenterologist if you have persistent diarrhea, blood in stool, unexplained weight loss, or a calprotectin that comes back elevated. Those findings warrant a real workup regardless of what the ratio says. An odd ratio with no symptoms and clean inflammatory and metabolic markers is a curiosity, not a problem.